Similar to TRPV4, TRPC1 is also increased in GBM patients [239] and is involved in glioma cell proliferation [240,241] and migration via regulating chemotaxis at the leading edge of migratory glioma cells [242,243]. Here, TRPV4 is linked to central nervous system cancer.